DCBLD1 and non-small cell lung carcinoma: In three cancers (NSCLC, invasive breast carcinoma and HNSCC) for which DCBLD1 had prognostic value, high DCBLD1 expression showed statistically significant upregulation of the integrin signaling pathway.